ABSTRACT Pituitary adenomas comprise approximately 10-20% of intracranial tumors. Non-
functioning pituitary adenomas (NFPAs) are benign adenohypophyseal tumors not …

Background: Numerous studies have explored the relationship between social participation,
depression, cognitive function, and life satisfaction in community-dwelling older adults …

Context Insight into the current landscape of patient-reported outcome (PRO) measures
(PROM) and differences between PROs and conventional biochemical outcomes is pivotal …

Introduction Pituitary tumors may have a considerable impact on patients' functional status,
including paid employment, yet research in this area is sparse. Objective To describe work …

Pituitary diseases are rare conditions with severe chronic multiorgan and multisystemic
morbidity requiring complex multidisciplinary treatment and usually life-long drug treatment …

Introduction The low prevalence of pituitary diseases makes patient autonomy crucial, and
self-management programs should be more common. Objectives To assess the efficacy of …

Objective To evaluate the quality of life (QoL) in patients with pituitary adenomas in
comparison with healthy Mexican population QoL scores. Design & Measurements Cross …

Protein ubiquitination is an important post-translational modification that is associated with
multiple diseases, including pituitary adenomas (PAs). Protein ubiquitination profiling in …

Introduction Automation of routine clinical data shows promise in relieving health systems of
the burden associated with manual data collection. Identifying consistent points of …

Over the last 2 decades, advances in the diagnosis and management of pituitary diseases
have made it possible to attain an endocrine “cure” in a large proportion of patients. In other …